Clinical Trial Update: AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing AT versus TP as neoadjuvant chemotherapy for HER2-negative early breast cancer is ongoing, with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AT
• TP

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: HER2-negative Breast Cancer | Phase 2 | Status: UNKNOWN